株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

リスクベースモニタリング (RBM) ソフトウェアの世界市場 ~2025年

Risk-based Monitoring Software Market by End User (Pharma & Biopharmaceutical Co., Medical Device Co., CROs), Delivery Mode (Web Hosted, On-premise, Cloud-based), Type (Enterprise, Site), Component (Software, Services) - Global Forecast to 2025

発行 MarketsandMarkets 商品コード 938893
出版日 ページ情報 英文 138 Pages
即納可能
価格
本日の銀行送金レート: 1USD=108.54円で換算しております。
リスクベースモニタリング (RBM) ソフトウェアの世界市場 ~2025年 Risk-based Monitoring Software Market by End User (Pharma & Biopharmaceutical Co., Medical Device Co., CROs), Delivery Mode (Web Hosted, On-premise, Cloud-based), Type (Enterprise, Site), Component (Software, Services) - Global Forecast to 2025
出版日: 2020年05月19日 ページ情報: 英文 138 Pages
概要

リスクベースのモニタリング(RBM)ソフトウェアの市場は予測期間中13.3%のCAGRで推移し、2020年の2億7300万米ドルから、2025年には5億1100万米ドルに成長すると予想されています。RBMソリューションのコスト効率および時間効率の高さ、臨床試験件数の増加、臨床試験をサポートする政府資金・助成金の増加などの要因が同市場の成長を推進しています。タイプ別で見ると、2020年においてはエンタープライズRBMソフトウェア部門が最大の市場シェアを保持する見通しです。また、コンポーネント別では、ソフトウェア部門がサービス部門に勝るシェアを保持する見通しです。さらに地域別では、2020年においては北米地域が市場の主導的立場にありましたが、予測期間中はアジア太平洋地域が最高の成長を記録する見通しです。同地域の成長は、臨床試験をサポートする政府資金の増加、先進国と比較して厳格でない規制ガイドラインの存在、大規模な患者基盤、臨床試験実施における低い運用コスト、欧州・北米における試験ボランティアの不足、地域の製薬会社およびCRO数の増加などの要因が影響しています。

当レポートでは、世界のリスクベースモニタリングソフトウェアの市場を調査し、市場および製品の概要、市場成長への各種影響因子および市場機会の分析、タイプ・コンポーネント・エンドユーザー・地域/主要国別の動向と市場規模の推移と予測、競合環境、主要企業のプロファイルなどをまとめています。

938893_4.2 RISK-BASED MONITORING SOFTWARE MARKET SHARE, BY TYPE, 2020 VS. 2025_FIGURE 14

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

第5章 市場概要

  • イントロダクション
  • 市場力学
    • 促進要因
    • 抑制要因
    • 市場機会
    • 課題

第6章 リスクベースモニタリングソフトウェア市場の分析・予測:タイプ別

  • イントロダクション
  • エンタープライズRBMソフトウェア
  • サイトRBMソフトウェア

第7章 リスクベースモニタリングソフトウェア市場の分析・予測:コンポーネント別

  • イントロダクション
  • ソフトウェア
  • サービス

第8章 リスクベースモニタリングソフトウェア市場の分析・予測:デリバリーモード別

  • イントロダクション
  • Webベース(オンデマンド)
  • ライセンス企業(オンプレミス)
  • クラウドベース(SAAS)

第9章 リスクベースモニタリングソフトウェア市場の分析・予測:エンドユーザー別

  • イントロダクション
  • 医薬品・バイオ医薬品企業
  • CRO
  • 医療機器企業
  • その他

第10章 リスクベースモニタリングソフトウェア市場の分析・予測:地域別

  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋
  • その他の地域

第11章 競合情勢

  • 概要
  • 市場シェア分析
  • 競合リーダーシップマッピング
  • 競合シナリオ
    • 製品の発売・機能強化
    • 資金調達
    • 買収
    • 提携
    • 協力

第12章 企業プロファイル

  • ORACLE
  • MEDIDATA SOLUTIONS
  • PAREXEL (PAMPLONA CAPITAL MANAGEMENT)
  • BIOCLINICA
  • BIO-OPTRONICS
  • IBM
  • DATATRAK
  • VEEVA SYSTEMS
  • DSG
  • MASTERCONTROL
  • ERT
  • FORTE RESEARCH SYSTEMS
  • MEDNET SOLUTIONS
  • ARISGLOBAL
  • ANJU SOFTWARE
  • AXISIT
  • TECHSOL CORPORATION
  • OPENCLINICA
  • CRF HEALTH
  • COVANCE INC.

第13章 付録

図表

LIST OF TABLES

  • TABLE 1 NUMBER OF REGISTERED CLINICAL TRIAL STUDIES GLOBALLY, 2002-2019 37
  • TABLE 2 RISK-BASED MONITORING SOFTWARE MARKET, BY TYPE, 2018-2025 (USD MILLION) 41
  • TABLE 3 ENTERPRISE RBM SOFTWARE MARKET, BY REGION, 2018-2025 (USD MILLION) 41
  • TABLE 4 NORTH AMERICA: ENTERPRISE RBM SOFTWARE MARKET, BY COUNTRY, 2018-2025 (USD MILLION) 42
  • TABLE 5 EUROPE: ENTERPRISE RBM SOFTWARE MARKET, BY COUNTRY, 2018-2025 (USD MILLION) 42
  • TABLE 6 ASIA PACIFIC: ENTERPRISE RBM SOFTWARE MARKET, BY COUNTRY, 2018-2025 (USD MILLION) 42
  • TABLE 7 SITE RBM SOFTWARE MARKET, BY REGION, 2018-2025 (USD MILLION) 43
  • TABLE 8 NORTH AMERICA: SITE RBM SOFTWARE MARKET, BY COUNTRY, 2018-2025 (USD MILLION) 43
  • TABLE 9 EUROPE: SITE RBM SOFTWARE MARKET, BY COUNTRY, 2018-2025 (USD MILLION) 44
  • TABLE 10 ASIA PACIFIC: SITE RBM SOFTWARE MARKET, BY COUNTRY, 2018-2025 (USD MILLION) 44
  • TABLE 11 RISK-BASED MONITORING SOFTWARE MARKET, BY COMPONENT, 2018-2025 (USD MILLION) 46
  • TABLE 12 RISK-BASED MONITORING SOFTWARE MARKET FOR SOFTWARE, BY REGION, 2018-2025 (USD MILLION) 46
  • TABLE 13 NORTH AMERICA: RISK-BASED MONITORING SOFTWARE MARKET FOR SOFTWARE, BY COUNTRY, 2018-2025 (USD MILLION) 47
  • TABLE 14 EUROPE: RISK-BASED MONITORING SOFTWARE MARKET FOR SOFTWARE, BY COUNTRY, 2018-2025 (USD MILLION) 47
  • TABLE 15 ASIA PACIFIC: RISK-BASED MONITORING SOFTWARE MARKET FOR SOFTWARE, BY COUNTRY, 2018-2025 (USD MILLION) 47
  • TABLE 16 RISK-BASED MONITORING SOFTWARE MARKET FOR SERVICES, BY REGION, 2018-2025 (USD MILLION) 48
  • TABLE 17 NORTH AMERICA: RISK-BASED MONITORING SOFTWARE MARKET FOR SERVICES, BY COUNTRY, 2018-2025 (USD MILLION) 48
  • TABLE 18 EUROPE: RISK-BASED MONITORING SOFTWARE MARKET FOR SERVICES, BY COUNTRY, 2018-2025 (USD MILLION) 49
  • TABLE 19 ASIA PACIFIC: RISK-BASED MONITORING SOFTWARE MARKET FOR SERVICES, BY COUNTRY, 2018-2025 (USD MILLION) 49
  • TABLE 20 RISK-BASED MONITORING SOFTWARE MARKET, BY DELIVERY MODE, 2018-2025 (USD MILLION) 51
  • TABLE 21 RISK-BASED MONITORING SOFTWARE MARKET FOR WEB-BASED DELIVERY, BY REGION, 2018-2025 (USD MILLION) 52
  • TABLE 22 NORTH AMERICA: RISK-BASED MONITORING SOFTWARE MARKET FOR WEB-BASED DELIVERY, BY COUNTRY, 2018-2025 (USD MILLION) 52
  • TABLE 23 EUROPE: RISK-BASED MONITORING SOFTWARE MARKET FOR WEB-BASED DELIVERY, BY COUNTRY, 2018-2025 (USD MILLION) 52
  • TABLE 24 ASIA PACIFIC: RISK-BASED MONITORING SOFTWARE MARKET FOR WEB-BASED DELIVERY, BY COUNTRY, 2018-2025 (USD MILLION) 53
  • TABLE 25 RISK-BASED MONITORING SOFTWARE MARKET FOR LICENSED ENTERPRISE DELIVERY, BY REGION, 2018-2025 (USD MILLION) 54
  • TABLE 26 NORTH AMERICA: RISK-BASED MONITORING SOFTWARE MARKET FOR LICENSED ENTERPRISE DELIVERY, BY COUNTRY, 2018-2025 (USD MILLION) 54
  • TABLE 27 EUROPE: RISK-BASED MONITORING SOFTWARE MARKET FOR LICENSED ENTERPRISE DELIVERY, BY COUNTRY, 2018-2025 (USD MILLION) 54
  • TABLE 28 ASIA PACIFIC: RISK-BASED MONITORING SOFTWARE MARKET FOR LICENSED ENTERPRISE DELIVERY, BY COUNTRY, 2018-2025 (USD MILLION) 55
  • TABLE 29 RISK-BASED MONITORING SOFTWARE MARKET FOR CLOUD-BASED DELIVERY, BY REGION, 2018-2025 (USD MILLION) 55
  • TABLE 30 NORTH AMERICA: RISK-BASED MONITORING SOFTWARE MARKET FOR CLOUD-BASED DELIVERY, BY COUNTRY, 2018-2025 (USD MILLION) 56
  • TABLE 31 EUROPE: RISK-BASED MONITORING SOFTWARE MARKET FOR CLOUD-BASED DELIVERY, BY COUNTRY, 2018-2025 (USD MILLION) 56
  • TABLE 32 ASIA PACIFIC: RISK-BASED MONITORING SOFTWARE MARKET FOR CLOUD-BASED DELIVERY, BY COUNTRY, 2018-2025 (USD MILLION) 56
  • TABLE 33 RISK-BASED MONITORING SOFTWARE MARKET, BY END USER, 2018-2025 (USD MILLION) 58
  • TABLE 34 RISK-BASED MONITORING SOFTWARE MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2025 (USD MILLION) 59
  • TABLE 35 NORTH AMERICA: RISK-BASED MONITORING SOFTWARE MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2025 (USD MILLION) 59
  • TABLE 36 EUROPE: RISK-BASED MONITORING SOFTWARE MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2025 (USD MILLION) 59
  • TABLE 37 ASIA PACIFIC: RISK-BASED MONITORING SOFTWARE MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2025 (USD MILLION) 60
  • TABLE 38 RISK-BASED MONITORING SOFTWARE MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2025 (USD MILLION) 60
  • TABLE 39 NORTH AMERICA: RISK-BASED MONITORING SOFTWARE MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2025 (USD MILLION) 61
  • TABLE 40 EUROPE: RISK-BASED MONITORING SOFTWARE MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2025 (USD MILLION) 61
  • TABLE 41 ASIA PACIFIC: RISK-BASED MONITORING SOFTWARE MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2025 (USD MILLION) 61
  • TABLE 42 RISK-BASED MONITORING SOFTWARE MARKET FOR MEDICAL DEVICE COMPANIES, BY REGION, 2018-2025 (USD MILLION) 62
  • TABLE 43 NORTH AMERICA: RISK-BASED MONITORING SOFTWARE MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2018-2025 (USD MILLION) 62
  • TABLE 44 EUROPE: RISK-BASED MONITORING SOFTWARE MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2018-2025 (USD MILLION) 63
  • TABLE 45 ASIA PACIFIC: RISK-BASED MONITORING SOFTWARE MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2018-2025 (USD MILLION) 63
  • TABLE 46 RISK-BASED MONITORING SOFTWARE MARKET FOR OTHER END USERS, BY REGION, 2018-2025 (USD MILLION) 64
  • TABLE 47 NORTH AMERICA: RISK-BASED MONITORING SOFTWARE MARKET FOR OTHER END USERS, BY COUNTRY, 2018-2025 (USD MILLION) 64
  • TABLE 48 EUROPE: RISK-BASED MONITORING SOFTWARE MARKET FOR OTHER END USERS, BY COUNTRY, 2018-2025 (USD MILLION) 64
  • TABLE 49 ASIA PACIFIC: RISK-BASED MONITORING SOFTWARE MARKET FOR OTHER END USERS, BY COUNTRY, 2018-2025 (USD MILLION) 65
  • TABLE 50 RISK-BASED MONITORING SOFTWARE MARKET, BY REGION, 2018-2025 (USD MILLION) 67
  • TABLE 51 NORTH AMERICA: RISK-BASED MONITORING SOFTWARE MARKET, BY COUNTRY, 2018-2025 (USD MILLION) 69
  • TABLE 52 NORTH AMERICA: RISK-BASED MONITORING SOFTWARE MARKET, BY TYPE, 2018-2025 (USD MILLION) 69
  • TABLE 53 NORTH AMERICA: RISK-BASED MONITORING SOFTWARE MARKET, BY COMPONENT, 2018-2025 (USD MILLION) 69
  • TABLE 54 NORTH AMERICA: RISK-BASED MONITORING SOFTWARE MARKET, BY DELIVERY MODE, 2018-2025 (USD MILLION) 70
  • TABLE 55 NORTH AMERICA: RISK-BASED MONITORING SOFTWARE MARKET, BY END USER, 2018-2025 (USD MILLION) 70
  • TABLE 56 US: RISK-BASED MONITORING SOFTWARE MARKET, BY TYPE, 2018-2025 (USD MILLION) 71
  • TABLE 57 US: RISK-BASED MONITORING SOFTWARE MARKET, BY COMPONENT, 2018-2025 (USD MILLION) 71
  • TABLE 58 US: RISK-BASED MONITORING SOFTWARE MARKET, BY DELIVERY MODE, 2018-2025 (USD MILLION) 71
  • TABLE 59 US: RISK-BASED MONITORING SOFTWARE MARKET, BY END USER, 2018-2025 (USD MILLION) 72
  • TABLE 60 CANADA: RISK-BASED MONITORING SOFTWARE MARKET, BY TYPE, 2018-2025 (USD MILLION) 72
  • TABLE 61 CANADA: RISK-BASED MONITORING SOFTWARE MARKET, BY COMPONENT, 2018-2025 (USD MILLION) 73
  • TABLE 62 CANADA: RISK-BASED MONITORING SOFTWARE MARKET, BY DELIVERY MODE, 2018-2025 (USD MILLION) 73
  • TABLE 63 CANADA: RISK-BASED MONITORING SOFTWARE MARKET, BY END USER, 2018-2025 (USD MILLION) 73
  • TABLE 64 EUROPE: RISK-BASED MONITORING SOFTWARE MARKET, BY COUNTRY, 2018-2025 (USD MILLION) 75
  • TABLE 65 EUROPE: RISK-BASED MONITORING SOFTWARE MARKET, BY TYPE, 2018-2025 (USD MILLION) 75
  • TABLE 66 EUROPE: RISK-BASED MONITORING SOFTWARE MARKET, BY COMPONENT, 2018-2025 (USD MILLION) 75
  • TABLE 67 EUROPE: RISK-BASED MONITORING SOFTWARE MARKET, BY DELIVERY MODE, 2018-2025 (USD MILLION) 76
  • TABLE 68 EUROPE: RISK-BASED MONITORING SOFTWARE MARKET, BY END USER, 2018-2025 (USD MILLION) 76
  • TABLE 69 GERMANY: RISK-BASED MONITORING SOFTWARE MARKET, BY TYPE, 2018-2025 (USD MILLION) 77
  • TABLE 70 GERMANY: RISK-BASED MONITORING SOFTWARE MARKET, BY COMPONENT, 2018-2025 (USD MILLION) 77
  • TABLE 71 GERMANY: RISK-BASED MONITORING SOFTWARE MARKET, BY DELIVERY MODE, 2018-2025 (USD MILLION) 77
  • TABLE 72 GERMANY: RISK-BASED MONITORING SOFTWARE MARKET, BY END USER, 2018-2025 (USD MILLION) 78
  • TABLE 73 UK: RISK-BASED MONITORING SOFTWARE MARKET, BY TYPE, 2018-2025 (USD MILLION) 78
  • TABLE 74 UK: RISK-BASED MONITORING SOFTWARE MARKET, BY COMPONENT, 2018-2025 (USD MILLION) 79
  • TABLE 75 UK: RISK-BASED MONITORING SOFTWARE MARKET, BY DELIVERY MODE, 2018-2025 (USD MILLION) 79
  • TABLE 76 UK: RISK-BASED MONITORING SOFTWARE MARKET, BY END USER, 2018-2025 (USD MILLION) 79
  • TABLE 77 FRANCE: RISK-BASED MONITORING SOFTWARE MARKET, BY TYPE, 2018-2025 (USD MILLION) 80
  • TABLE 78 FRANCE: RISK-BASED MONITORING SOFTWARE MARKET, BY COMPONENT, 2018-2025 (USD MILLION) 80
  • TABLE 79 FRANCE: RISK-BASED MONITORING SOFTWARE MARKET, BY DELIVERY MODE, 2018-2025 (USD MILLION) 81
  • TABLE 80 FRANCE: RISK-BASED MONITORING SOFTWARE MARKET, BY END USER, 2018-2025 (USD MILLION) 81
  • TABLE 81 ROE: RISK-BASED MONITORING SOFTWARE MARKET, BY TYPE, 2018-2025 (USD MILLION) 82
  • TABLE 82 ROE: RISK-BASED MONITORING SOFTWARE MARKET, BY COMPONENT, 2018-2025 (USD MILLION) 82
  • TABLE 83 ROE: RISK-BASED MONITORING SOFTWARE MARKET, BY DELIVERY MODE, 2018-2025 (USD MILLION) 82
  • TABLE 84 ROE: RISK-BASED MONITORING SOFTWARE MARKET, BY END USER, 2018-2025 (USD MILLION) 83
  • TABLE 85 ASIA PACIFIC: RISK-BASED MONITORING SOFTWARE MARKET, BY COUNTRY, 2018-2025 (USD MILLION) 85
  • TABLE 86 ASIA PACIFIC: RISK-BASED MONITORING SOFTWARE MARKET, BY TYPE, 2018-2025 (USD MILLION) 85
  • TABLE 87 ASIA PACIFIC: RISK-BASED MONITORING SOFTWARE MARKET, BY COMPONENT, 2018-2025 (USD MILLION) 85
  • TABLE 88 ASIA PACIFIC: RISK-BASED MONITORING SOFTWARE MARKET, BY DELIVERY MODE, 2018-2025 (USD MILLION) 86
  • TABLE 89 ASIA PACIFIC: RISK-BASED MONITORING SOFTWARE MARKET, BY END USER, 2018-2025 (USD MILLION) 86
  • TABLE 90 CHINA: RISK-BASED MONITORING SOFTWARE MARKET, BY TYPE, 2018-2025 (USD MILLION) 87
  • TABLE 91 CHINA: RISK-BASED MONITORING SOFTWARE MARKET, BY COMPONENT, 2018-2025 (USD MILLION) 87
  • TABLE 92 CHINA: RISK-BASED MONITORING SOFTWARE MARKET, BY DELIVERY MODE, 2018-2025 (USD MILLION) 87
  • TABLE 93 CHINA: RISK-BASED MONITORING SOFTWARE MARKET, BY END USER, 2018-2025 (USD MILLION) 88
  • TABLE 94 JAPAN: RISK-BASED MONITORING SOFTWARE MARKET, BY TYPE, 2018-2025 (USD MILLION) 88
  • TABLE 95 JAPAN: RISK-BASED MONITORING SOFTWARE MARKET, BY COMPONENT, 2018-2025 (USD MILLION) 89
  • TABLE 96 JAPAN: RISK-BASED MONITORING SOFTWARE MARKET, BY DELIVERY MODE, 2018-2025 (USD MILLION) 89
  • TABLE 97 JAPAN: RISK-BASED MONITORING SOFTWARE MARKET, BY END USER, 2018-2025 (USD MILLION) 89
  • TABLE 98 INDIA: RISK-BASED MONITORING SOFTWARE MARKET, BY TYPE, 2018-2025 (USD MILLION) 90
  • TABLE 99 INDIA: RISK-BASED MONITORING SOFTWARE MARKET, BY COMPONENT, 2018-2025 (USD MILLION) 90
  • TABLE 100 INDIA: RISK-BASED MONITORING SOFTWARE MARKET, BY DELIVERY MODE, 2018-2025 (USD MILLION) 91
  • TABLE 101 INDIA: RISK-BASED MONITORING SOFTWARE MARKET, BY END USER, 2018-2025 (USD MILLION) 91
  • TABLE 102 ROAPAC: RISK-BASED MONITORING SOFTWARE MARKET, BY TYPE, 2018-2025 (USD MILLION) 92
  • TABLE 103 ROAPAC: RISK-BASED MONITORING SOFTWARE MARKET, BY COMPONENT, 2018-2025 (USD MILLION) 92
  • TABLE 104 ROAPAC: RISK-BASED MONITORING SOFTWARE MARKET, BY DELIVERY MODE, 2018-2025 (USD MILLION) 92
  • TABLE 105 ROAPAC: RISK-BASED MONITORING SOFTWARE MARKET, BY END USER, 2018-2025 (USD MILLION) 93
  • TABLE 106 ROW: RISK-BASED MONITORING SOFTWARE MARKET, BY TYPE, 2018-2025 (USD MILLION) 94
  • TABLE 107 ROW: RISK-BASED MONITORING SOFTWARE MARKET, BY COMPONENT, 2018-2025 (USD MILLION) 95
  • TABLE 108 ROW: RISK-BASED MONITORING SOFTWARE MARKET, BY DELIVERY MODE, 2018-2025 (USD MILLION) 95
  • TABLE 109 ROW: RISK-BASED MONITORING SOFTWARE MARKET, BY END USER, 2018-2025 (USD MILLION) 95
  • TABLE 110 KEY PRODUCT LAUNCHES & ENHANCEMENTS 100
  • TABLE 111 KEY FUNDING 100
  • TABLE 112 KEY ACQUISITIONS 101
  • TABLE 113 KEY PARTNERSHIPS 101
  • TABLE 114 KEY COLLABORATIONS 102

LIST OF FIGURES

  • FIGURE 1 RESEARCH DESIGN 20
  • FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 22
  • FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 24
  • FIGURE 4 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (1/2) 25
  • FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2/2) 25
  • FIGURE 6 MARKET SIZE ESTIMATION BASED ON PARENT MARKET SIZE (APPROACH 2) 26
  • FIGURE 7 DATA TRIANGULATION METHODOLOGY 28
  • FIGURE 8 RISK-BASED MONITORING SOFTWARE MARKET, BY TYPE, 2020 VS. 2025 (USD MILLION) 30
  • FIGURE 9 RISK-BASED MONITORING SOFTWARE MARKET, BY COMPONENT, 2020 VS. 2025 (USD MILLION) 31
  • FIGURE 10 RISK-BASED MONITORING SOFTWARE MARKET, BY DELIVERY MODE, 2020 VS. 2025 (USD MILLION) 31
  • FIGURE 11 RISK-BASED MONITORING SOFTWARE MARKET, BY END USER, 2020 VS. 2025 (USD MILLION) 32
  • FIGURE 12 GEOGRAPHICAL SNAPSHOT OF THE RISK-BASED MONITORING SOFTWARE MARKET 33
  • FIGURE 13 RISING NUMBER OF CLINICAL TRIALS TO DRIVE MARKET GROWTH 34
  • FIGURE 14 ENTERPRISE RBM SOFTWARE SEGMENT WILL CONTINUE TO DOMINATE THE RBM SOFTWARE MARKET IN 2025 34
  • FIGURE 15 SOFTWARE SEGMENT ACCOUNTED FOR THE LARGEST MARKET SHARE IN 2019 35
  • FIGURE 16 ASIA PACIFIC TO REGISTER THE HIGHEST GROWTH IN THE RBM SOFTWARE MARKET DURING THE FORECAST PERIOD 35
  • FIGURE 17 RISK-BASED MONITORING SOFTWARE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, & CHALLENGES 36
  • FIGURE 18 NORTH AMERICA: RISK-BASED MONITORING SOFTWARE MARKET SNAPSHOT 68
  • FIGURE 19 EUROPE: RISK-BASED MONITORING SOFTWARE MARKET SNAPSHOT 74
  • FIGURE 20 APAC: RISK-BASED MONITORING SOFTWARE MARKET SNAPSHOT 84
  • FIGURE 21 ROW: RISK-BASED MONITORING SOFTWARE MARKET SNAPSHOT 94
  • FIGURE 22 KEY DEVELOPMENTS IN THE RISK-BASED MONITORING SOFTWARE MARKET 96
  • FIGURE 23 RISK-BASED MONITORING SOFTWARE MARKET SHARE ANALYSIS (2018) 97
  • FIGURE 24 RISK-BASED MONITORING SOFTWARE MARKET (GLOBAL): COMPETITIVE LEADERSHIP MAPPING, 2018 99
  • FIGURE 25 ORACLE: COMPANY SNAPSHOT (2018) 103
  • FIGURE 26 MEDIDATA SOLUTIONS: COMPANY SNAPSHOT (2018) 105
  • FIGURE 27 PAREXEL: COMPANY SNAPSHOT (2016) 107
  • FIGURE 28 IBM: COMPANY SNAPSHOT (2018) 112
  • FIGURE 29 DATATRAK: COMPANY SNAPSHOT (2018) 113
  • FIGURE 30 VEEVA SYSTEMS: COMPANY SNAPSHOT (2018) 115
目次
Product Code: HIT 7651

"Risk-based monitoring (RBM) software market is projected to grow at a CAGR of 13.3%."

The RBM software market is expected to reach USD 511 million by 2025 from USD 273 million in 2020, at a CAGR of 13.3% during the forecast period. The RBM software market has witnessed various advancements in products and their approvals to meet the needs of the pharmaceutical research and development industry worldwide.

Growth in the market can primarily be attributed to factors such as the cost and time efficiency of RBM solutions, rising number of clinical trials, and increasing government funding and grants to support clinical trials

"The Enterprise RBM Software segment to hold the largest market share in 2020."

Based on type, the RBM software market is segmented into Enterprise RBM Software and Site RBM Software. In 2020, the Enterprise RBM Software segment is expected to command the largest share of the RBM software market. The large share of this segment can be attributed to the widespread adoption of enterprise RBM software by end-users as it allows all authorized professionals to have access to clinical trial data and metrics placed at a centralized location.

"The software component segment to hold the largest market share in 2020."

Based on the component, the RBM software market is segmented into Software and Services. In 2020, the software segment is expected to command the largest share of the RBM software market. The large share of this segment can be attributed to the increasing R&D expenditure in the life science and clinical research industries, increasing number of clinical trials, and rising customer base

"The pharmaceutical and biopharmaceutical companies segment to hold the largest market share in 2020."

Based on end-user, the RBM software market is segmented into pharmaceutical and biopharmaceutical companies, CROs, medical device companies, and other end users. In 2020, the pharmaceutical and biopharmaceutical companies segment is expected to command the largest share of the RBM software market. The increasing R&D expenditure of pharmaceutical and biopharmaceutical companies is the major factor driving the growth of this end-user segment.

"The Asia Pacific region to witness the highest growth during the forecast period."

Geographically, North America dominated the global RBM software market in 2020. However, the Asia Pacific market is expected to register the highest during the forecast period. The major factors driving the growth of the Asia Pacific market include increasing government funding to support clinical trials, the presence of less stringent regulatory guidelines as compared to developed nations, a large patient base, low operating costs for conducting clinical trials, shortage of trial volunteers in Europe and North America, and the growing number of pharmaceutical companies and CROs in the region.

Break of primary participants was as mentioned below:

  • By Company Type: Tier I: 55%, Tier II: 25%, Tier III: 20%
  • By Designation: C-Level Executives: 35%, Directors: 25%, Others: 40%
  • By Region: North America: 20%, Europe: 25%, Asia Pacific : 40%, RoW: 15%

Oracle (US), Medidata Solutions (US), and Parexel International Corporation (US) were the leading players in the RBM software market.

Research Coverage

This report studies the RBM software market based on type, component, delivery mode, end-user, and region. The report also studies the different factors (such as drivers, restraints, challenges, and opportunities) affecting the market growth. It analyzes the opportunities and challenges in the market and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to four main regions and respective countries.

Key Benefits of Buying the Report

This report focuses on various levels of analysis-industry trends, market shares of top players, and company profiles, which together form basic views and analyze the competitive landscape, emerging segments of the RBM software market, and their drivers, restraints, and opportunities. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the RBM software and garner greater market shares.

TABLE OF CONTENTS

1 INTRODUCTION 17

  • 1.1 OBJECTIVES OF THE STUDY 17
  • 1.2 MARKET DEFINITION 17
    • 1.2.1 MARKET SCOPE 18
    • 1.2.2 MARKETS COVERED 18
    • 1.2.3 YEARS CONSIDERED FOR THE STUDY 19
  • 1.3 CURRENCY 19
  • 1.4 LIMITATIONS 19
  • 1.5 STAKEHOLDERS 19

2 RESEARCH METHODOLOGY 20

  • 2.1 RESEARCH DATA 20
    • 2.1.1 SECONDARY DATA 21
      • 2.1.1.1 Secondary sources 21
    • 2.1.2 PRIMARY DATA 22
      • 2.1.2.1 Primary sources 23
    • 2.1.3 MARKET SIZE ESTIMATION METHODOLOGY 23
    • 2.1.4 REVENUE MAPPING-BASED MARKET ESTIMATION (APPROACH 1) 24
    • 2.1.5 MARKET ESTIMATION USING PARENT MARKET SIZE (APPROACH 2) 26
  • 2.2 MARKET DATA ESTIMATION AND TRIANGULATION 28
  • 2.3 ASSUMPTIONS OF THE STUDY 29

3 EXECUTIVE SUMMARY 30

4 PREMIUM INSIGHTS 34

  • 4.1 RISK-BASED MONITORING SOFTWARE: MARKET OVERVIEW 34
  • 4.2 RISK-BASED MONITORING SOFTWARE MARKET SHARE, BY TYPE, 2020 VS. 2025 34
  • 4.3 RISK-BASED MONITORING SOFTWARE MARKET SHARE, BY COMPONENT, 2020 VS. 2025 35
  • 4.4 RISK-BASED MONITORING SOFTWARE MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 35

5 MARKET OVERVIEW 36

  • 5.1 INTRODUCTION 36
  • 5.2 MARKET DYNAMICS 36
    • 5.2.1 DRIVERS 36
      • 5.2.1.1 Cost and time efficiency of RBM solutions 36
      • 5.2.1.2 Rising number of clinical trials 37
      • 5.2.1.3 Increasing government funding and grants to support clinical trials 38
    • 5.2.2 RESTRAINTS 38
      • 5.2.2.1 High implementation costs 38
    • 5.2.3 OPPORTUNITIES 38
      • 5.2.3.1 Increased outsourcing of clinical trial processes to CROs 38
    • 5.2.4 CHALLENGES 39
      • 5.2.4.1 Dearth of skilled professionals for operating RBM solutions 39

6 RISK-BASED MONITORING SOFTWARE MARKET, BY TYPE 40

  • 6.1 INTRODUCTION 41
  • 6.2 ENTERPRISE RBM SOFTWARE 41
    • 6.2.1 ENTERPRISE RBM SOFTWARE DOMINATES THE RBM SOFTWARE MARKET 41
  • 6.3 SITE RBM SOFTWARE 43
    • 6.3.1 SITE RBM SOFTWARE OFFERS IMPROVED TRIAL MANAGEMENT 43

7 RISK-BASED MONITORING SOFTWARE MARKET, BY COMPONENT 45

  • 7.1 INTRODUCTION 46
  • 7.2 SOFTWARE 46
    • 7.2.1 GROWING ADOPTION OF CLINICAL TRIAL MANAGEMENT SOLUTIONS TO SUPPORT MARKET GROWTH 46
  • 7.3 SERVICES 48
    • 7.3.1 NEED FOR CONTINUOUS UPGRADE OF RBM SOFTWARE PRODUCTS HAS INCREASED THE DEMAND FOR SERVICES 48

8 RISK-BASED MONITORING SOFTWARE MARKET, BY DELIVERY MODE 50

  • 8.1 INTRODUCTION 51
  • 8.2 WEB-BASED (ON-DEMAND) 51
    • 8.2.1 ADVANTAGES SUCH AS EASY ACCESS & REDUCTION IN COSTS TO SUPPORT MARKET GROWTH 51
  • 8.3 LICENSED ENTERPRISE (ON-PREMISE) 53
    • 8.3.1 ON-PREMISE MODELS MINIMIZE RISKS ASSOCIATED WITH DATA BREACHES AND EXTERNAL ATTACKS 53
  • 8.4 CLOUD-BASED (SAAS) 55
    • 8.4.1 INCREASING ADOPTION OF CLOUD-BASED SOLUTIONS TO DRIVE MARKET GROWTH 55

9 RISK-BASED MONITORING SOFTWARE MARKET, BY END USER 57

  • 9.1 INTRODUCTION 58
  • 9.2 PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES 58
    • 9.2.1 INCREASED PHARMACEUTICAL R&D SPENDING TO DRIVE MARKET GROWTH 58
  • 9.3 CONTRACT RESEARCH ORGANIZATIONS (CROS) 60
    • 9.3.1 INCREASING OUTSOURCING OF CLINICAL RESEARCH ACTIVITIES BY PHARMACEUTICAL, BIOTECHNOLOGY, AND MEDICAL DEVICE COMPANIES TO DRIVE MARKET GROWTH 60
  • 9.4 MEDICAL DEVICE COMPANIES 62
    • 9.4.1 GOVERNMENT FUNDING TO SUPPORT MARKET GROWTH 62
  • 9.5 OTHER END USERS 63

10 RISK-BASED MONITORING SOFTWARE MARKET, BY REGION 66

  • 10.1 INTRODUCTION 67
  • 10.2 NORTH AMERICA 68
    • 10.2.1 US 70
      • 10.2.1.1 The US holds the largest share of the North American market 70
    • 10.2.2 CANADA 72
      • 10.2.2.1 Government funding to boost market growth 72
  • 10.3 EUROPE 74
    • 10.3.1 GERMANY 76
      • 10.3.1.1 Initiatives to boost digital health to propel market growth 76
    • 10.3.2 UK 78
      • 10.3.2.1 Favorable R&D scenario in the country to boost the adoption of RBM software 78
    • 10.3.3 FRANCE 80
      • 10.3.3.1 Lack of sufficient funding to restrain market growth in France 80
    • 10.3.4 ROE 81
  • 10.4 APAC 84
    • 10.4.1 CHINA 86
      • 10.4.1.1 Increased pharmaceutical R&D spending to drive market growth 86
    • 10.4.2 JAPAN 88
      • 10.4.2.1 Stringent regulatory scenario in Japan to restrain market growth 88
    • 10.4.3 INDIA 90
      • 10.4.3.1 Favorable pharmaceutical R&D scenario to drive the adoption of RBM software 90
    • 10.4.4 REST OF ASIA PACIFIC 91
  • 10.5 REST OF THE WORLD 93

11 COMPETITIVE LANDSCAPE 96

  • 11.1 OVERVIEW 96
  • 11.2 MARKET SHARE ANALYSIS 97
  • 11.3 COMPETITIVE LEADERSHIP MAPPING 98
    • 11.3.1 VISIONARY LEADERS 98
    • 11.3.2 INNOVATORS 98
    • 11.3.3 DYNAMIC DIFFERENTIATORS 98
    • 11.3.4 EMERGING COMPANIES 98
  • 11.4 COMPETITIVE SCENARIO 100
    • 11.4.1 PRODUCT LAUNCHES & ENHANCEMENTS 100
    • 11.4.2 FUNDING 100
    • 11.4.3 ACQUISITIONS 101
    • 11.4.4 PARTNERSHIPS 101
    • 11.4.5 COLLABORATIONS 102

12 COMPANY PROFILES 103

(Business overview, Products offered, Recent developments, MNM view)*

  • 12.1 ORACLE 103
  • 12.2 MEDIDATA SOLUTIONS 105
  • 12.3 PAREXEL (ACQUIRED BY PAMPLONA CAPITAL MANAGEMENT) 107
  • 12.4 BIOCLINICA 110
  • 12.5 BIO-OPTRONICS 111
  • 12.6 IBM 112
  • 12.7 DATATRAK 113
  • 12.8 VEEVA SYSTEMS 115
  • 12.9 DSG 117
  • 12.10 MASTERCONTROL 118
  • 12.11 ERT 119
  • 12.12 FORTE RESEARCH SYSTEMS 121
  • 12.13 MEDNET SOLUTIONS 122
  • 12.14 ARISGLOBAL 124
  • 12.15 ANJU SOFTWARE 125
  • 12.16 AXISIT 126
  • 12.17 TECHSOL CORPORATION 127
  • 12.18 OPENCLINICA 128
  • 12.19 CRF HEALTH 129
  • 12.20 COVANCE INC. 130

Business overview, Products offered, Recent developments, MNM view might not be captured in case of unlisted companies.

13 APPENDIX 131

  • 13.1 DISCUSSION GUIDE 131
  • 13.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL 134
  • 13.3 AVAILABLE CUSTOMIZATIONS 136
  • 13.4 RELATED REPORTS 136
  • 13.5 AUTHOR DETAILS 137